The tweet was deleted by the author.
But we saved everything 🙂.
Caribou Biosciences announced that it will participate in the 4th Annual BioConnect Investor Conference hosted by H.C. Wainwright in New York City next week.
The event brings together leading cell therapy and biotechnology firms, researchers, and investors to discuss advancements and investment opportunities in the sector. Caribou Biosciences is expected to showcase its work in CRISPR-based cell therapies as it seeks engagement with key stakeholders. Details on the company's agenda at the conference and planned presentations have not been specified. Details are being clarified.
Caribou Biosciences has recently maintained an active conference schedule. CEO Rachel Haurwitz was featured at the BofA Securities Health Care Conference in Las Vegas to discuss biotech advances. She also participated in a fireside chat webcast at a Bank of America event. The company continues to engage with investors and industry stakeholders through these appearances.